Precipio 2018 Revenues Increase 66% over 2017; Company Takes Substantial Cost-Cutting Measures Towards Profitability
February 14, 2019 08:18 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today its preliminary unaudited 2018 Revenues of $2.8M, representing 66%...
Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis
January 29, 2019 07:47 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced a recent radio show interview of Ilan Danieli, Precipio’s CEO, on...
Precipio Reports Strong Mid-Quarter Growth
December 12, 2018 08:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that based on metrics observed in its October and November revenue...
Precipio ICE COLD-PCR™ Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study
November 27, 2018 09:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that its ICE COLD-PCR™ (ICP) technology has been selected for a...
Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018
November 14, 2018 09:15 ET
|
Precipio, Inc.
Current Status, Existing and Future Applications of COLD-PCR for Cancer and Prenatal Diagnosis to Be Presented NEW HAVEN, Conn., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
October 18, 2018 07:36 ET
|
Precipio, Inc.
Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the...
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
October 16, 2018 07:47 ET
|
Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
Precipio Granted 180 Day NASDAQ Extension to Regain Compliance
September 27, 2018 07:37 ET
|
Precipio, Inc.
Enables Company to execute on strategic and commercial initiatives with the goal of meeting the minimum $1.00 price target NEW HAVEN, Conn., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer...
Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5M
September 21, 2018 09:18 ET
|
Precipio, Inc.
$82,000 monthly debt service to be eliminated with notes convertible into equity at a 65% premium to market NEW HAVEN, Conn., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics Company...
Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
July 18, 2018 07:37 ET
|
Precipio, Inc.
Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today...